Hello medical students and prospective #radonc applicants!
Please come to our Mayo Rochester Virtual Applicant Meet and Greet!
📅Tuesday, Aug 25th @ 6pm CST
🔗Link to register⤵️
https://t.co/ranBpws24S
Come meet our awesome residents! Hope to see you there!
🤩We are overjoyed to have @aadel_chaudhuri join our team! He is one of #radonc's biggest movers & shakers, and we can't wait to learn from his 👨🏽🔬expertise and 🧠innovative mindset! Welcome to the @MayoClinic family, Dr. Chaudhuri!
Today, we celebrate all the amazing women and gender minorities in #radonc with our allies! We welcome all to radiation oncology and thank you Marie Curie ☢ for blazing the trail 🌠! #WomenWhoCurie#WeWhoCurie
We are so grateful for the 39 amazing Advanced Practice Providers (APPs) that help make clinic go ‘round every day. Thanks for all you do and happy National APP Week!
We are 1️⃣week away from our #radonc virtual Meet & Greet 🤝🏽!
Register now to learn about all the great clinical, research, and leadership opportunities we have to offer!
https://t.co/Kydwi6e0OJ
Hey #medtwitter and prospective #radonc residents! Residency application season🍂is just around the corner!
Come to our virtual Meet & Greet to learn more about the awesome opportunities at Mayo RadOnc!
📅Sept 13
⌚7pm CST (8pm EST)
✏Register 👇🏽!
https://t.co/Kydwi6dsZb
Interesting analysis by @TRMcFar@neerajaiims suggest somatic BRCA mutation as early event in ontogeny of #prostatecancer#pcsm#GU21@ASCO https://t.co/AY2wiuhQx5 98% concordance on comprehensive genomic profiling of primary prostate tissue & cfDNA at median 23.6 mos difference
Kudos to @neerajaiims et al for setting such impressive benchmarks for OS benefit in #mCSPC. I remember starting fellowship at @cityofhope 15y ago with a limited arsenal of tx for #prostatecancer; now w #apalutamide & the many drugs that follow, the future is far 💡. @ASCO#GU21
#GU21@ASCO Updated results from IPATential trial metastatic CRPC #ProstateCancer 👉Pts with genomic mutations in PIK3CA/AKT1/PTEN had a ⬆️ magnitude of rPFS benefit with ipat + abi than without👇https://t.co/sfPU49vbh1 @OncoAlert@urotoday Next trial need genomic selection